Ciita Regulates Local and Systemic Immune Responses in a Combined rAAV- α -synuclein and Preformed Fibril-Induced Rat Model for Parkinson’s Disease
Journal of Parkinson’s Disease · 2024
DOI: 10.3233/jpd-240062 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Parkinson’s Disease, 2024. Verfasst von Filip Fredlund und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Medical Science, Translational Neurogenetics Unit, Lund University, Lund, Sweden. Hauptthemen laut MEDLINE: alpha-Synuclein, Disease Models, Animal, Parkinson Disease, Trans-Activators. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Parkinson’s disease (PD) is characterized by alpha-synuclein ( α-Syn) pathology, neurodegeneration and neuroinflammation. Human leukocyte antigen ( HLA) variants associated with PD and α-Syn specific CD4+ T lymphocytes in PD patients highlight the importance of antigen presentation in PD etiology. The class II transactivator (CIITA) regulates major histocompatibility complex class II (MHCII) expression. Reduced Ciita levels significantly increase α-Syn pathology, nigrostriatal neurodegeneration and behavioral deficits in α-Syn-induced rat PD models.
Objective
Characterize immune profiles associated with enhanced PD-like pathology observed in rats expressing lower Ciita levels (DA.VRA4) compared to the background strain (DA).
Methods
To model PD, we combined rAAV-mediated α-Syn overexpression in the substantia nigra with striatal injection of α-Syn preformed fibrils. Immune profiles in brain and blood were analyzed by flow cytometry and multiplexed ELISA in naïve rats, 4- and 8 weeks post rAAV injection.
Results
Flow cytometry showed Ciita-dependent regulation of MHCII on microglia, brain macrophages and circulating myeloid cells. The MHCII-dependent microglial response was highest at 4 weeks post rAAV injection, whereas the MHCII levels in circulating myeloid cells was highest at 8 weeks. There was no major infiltration of macrophages or T lymphocytes into the CNS in response to α-Syn and only subtle Ciita- and/or α-Syn-dependent changes in the T lymphocyte compartment. Lower Ciita levels were consistently associated with higher TNF levels in serum.
Conclusions
Ciita regulates susceptibility to PD-like pathology through minor but detectable changes in resident and peripheral immune cells and TNF levels, indicating that mild immunomodulatory therapies could have therapeutic effects in PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Experimental Medical Science, Translational Neurogenetics Unit, Lund University, Lund, Sweden.
- Department of Clinical Sciences, Inflammation and Stem Cell Therapy Group, Division of Clinical Neurophysiology, Lund University, Lund, Sweden.
- Institute of Environmental Medicine, Toxicology Unit, Karolinska Institutet, Stockholm, Sweden.
- Department of Pathology and Laboratory Medicine, Center for Neurodegenerative Disease Research, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Zitieren
APA
Fredlund, F., Jimenez-Ferrer, I., Grabert, K., Belfiori, L. F., Luk, K., & Swanberg, M. (2024). Ciita Regulates Local and Systemic Immune Responses in a Combined rAAV- α -synuclein and Preformed Fibril-Induced Rat Model for Parkinson’s Disease. Journal of Parkinson’s Disease. https://doi.org/10.3233/jpd-240062
Vancouver
Fredlund F, Jimenez-Ferrer I, Grabert K, Belfiori LF, Luk K, Swanberg M. Ciita Regulates Local and Systemic Immune Responses in a Combined rAAV- α -synuclein and Preformed Fibril-Induced Rat Model for Parkinson’s Disease. Journal of Parkinson’s Disease. 2024. doi:10.3233/jpd-240062
BibTeX
@article{Fredlund2024,
author = {Fredlund, Filip and Jimenez-Ferrer, Itzia and Grabert, Kathleen and Belfiori, Lautaro Francisco and Luk, Kelvin and Swanberg, Maria},
title = {Ciita Regulates Local and Systemic Immune Responses in a Combined rAAV- α -synuclein and Preformed Fibril-Induced Rat Model for Parkinson’s Disease},
journal = {Journal of Parkinson’s Disease},
year = {2024},
doi = {10.3233/jpd-240062}
}
EUVIMED